Evidence map›Paper›PMID 32692796›Full record

ArticleActa cirurgica brasileira2020

Investigation of the role of rosmarinic acid treatment in regulating inflammation, cell damage, and angiogenesis in rat ovarian torsion and detorsion models.

Uğur Değer, Yunus Çavuş

Open access · goldAbstract read
In one paragraph

Article in Acta cirurgica brasileira, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed, 1 pooled it
1.8field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 1 synthesis or guideline pooled it, 20 citations in OpenAlex.

  1. Pooled it
  2. Rosmarinic Acid Ameliorates PMAnimals : an open access journal from MDPI · 2026
    Article
  3. Article
  4. Article
  5. The therapeutic potential ofTurkish journal of biology = Turk biyoloji dergisi · 2025
    Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Uğur DeğerMD, Department of Obstetrics and Gynecology, Memorial Hospital, Diyarbakır, Turkey. Technical procedures, histopathological examinations, manuscript preparation and writing, final approval.ORCID http://orcid.org/0000-0002-4227-5091
Yunus ÇavuşMD, Department of Obstetrics and Gynecology, Memorial Hospital, Diyarbakır, Turkey. Technical procedures, histopathological examinations, manuscript preparation and writing, final approval.ORCID http://orcid.org/0000-0001-5739-3106
Diyarbakır Askeri Hastanesi · TR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeTo investigate the protective effect of rosmarinic acid (RA) in ovarian ischemia/reperfusion injury using biochemical, histopathological, and immunohistochemical methods.

methodsWistar female rats (n = 32) were randomly divided into four groups: control, ischemia, ischemia-reperfusion, and ischemia-reperfusion with RA. Rosmarinic acid was given at a dose of 50 mg/kg by oral gavage three hours after reperfusion. Malondialdehyde (MDA) levels and glutathione peroxidase (GSH-Px) activities were determined in the ovary tissue homogenates for each rat.

resultsIn the ischemia-reperfusion with RA group, the epithelial cells are regularly regulated at the periphery, and the degenerative changes in preantral and antral follicle cells are reduced. Follicle cells and cells in the corpus luteum showed a decrease in vascular endothelial growth factor (VEGF) expression, while VEGF demonstrated a positive reaction in vascular endothelial cells and stromal cells. The TNF-α expression due to the decreased degenerative effect and inflammation was positive in the macrophage cells. The expression of caspase-3 as an apoptosis change was negative in antral follicle cells and granular cells around the antral follicle.

conclusionDifferent doses of RA may be useful in preventing ischemic damage after vascularization, inflammation, and apoptotic development after ischemia/reperfusion.

Indexed as

CinnamatesDepsidesOvarian DiseasesReperfusion InjuryVascular Endothelial Growth Factor AAnimalsAntioxidantsEndothelial CellsFemaleInflammationMalondialdehydeRatsRats, WistarRosmarinic AcidTorsion AbnormalityAntioxidantsCinnamatesDepsidesMalondialdehydeRosmarinic AcidVascular Endothelial Growth Factor A

Identifiers

PMID32692796
PMCPMC7251978
OpenAlexW3027968127

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.